September 24, 2020
DURHAM, N.H.— The University of New Hampshire will receive $1.8 million from the National Institutes of Health (NIH) that will further molecular research to better understand drug interactions at the cellular level and help lead to the development of new targeted drugs to treat wide-spread metabolic, growth, neurological and visual disorders including diabetes and cancer. “This is an exciting opportunity to support some of our preliminary research that showed promise in new protein drug targets... - Read Full Article

UNH in the News

Tweets by @UNHNews